Diplomat Pharmacy Inc.’s Registered Common Stock Offering

Cravath represented the underwriters, led by Credit Suisse and Morgan Stanley, in connection with the US$285 million registered common stock offering of Diplomat Pharmacy, Inc., the largest independent specialty pharmacy in the United States. The shares were listed on the New York Stock Exchange. The transaction closed on March 31, 2015.

The Cravath team included partner William J. Whelan III and associate Scott J. Oudheusden. William F. Roegge also worked on this matter.